R&D

NVS
Favicon Fierce Pharma

Novartis pledges nearly $480M to bolster China production, R&D

Amid a spate of pharma investments in China, Novartis is the latest drugmaker lining up to bolster its R&D and production operations in the country.
Fraiser Kansteiner Mar 23, 2026 10:35am
Prune

Pfizer drops another early cancer candidate from Seagen

Mar 19, 2026 12:56pm
AI artificial intelligence factory cloud

Roche inks Nvidia expansion to bolster AI factory

Mar 16, 2026 5:58pm
One extinguished candle on dark background

Biotech unit Pfizer Ignite flames out

Mar 12, 2026 3:58pm
Graphic of a line of blocks with percentages on them with one block in yellow showing an arrow increasing

Small molecules are 'resurgent' in orphan drug R&D: Evaluate

Mar 12, 2026 10:30am
The flags of South Korea and the United States

Lilly pledges $500M to South Korea biopharma industry

Mar 10, 2026 12:00pm